UNSPSC 51292704: Cinanserin

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51292704

Definition

This classification denotes a serotonin antagonist with the molecular formula C20H24N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KI6J9OY7A3, chemically known as 2-propenamide, n-(2-((3-(dimethylamino)propyl)thio)phenyl)-3-phenyl- but generally known as cinanserin, which bears US NIH Compound Identifier 5475158. European Medicines Agency schedules Cinanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06285MIG.

Read the full definition

The term CINANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). CINANSERIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinanserin under HS 29309085 and SITC 51549. As of Q4 2014, CINANSERIN remains the US FDA Preferred Term for this commodity. Cinanserin bears US NLM identifiers UMLS ID C0008788 and NCI Concept Code C83624. SMILES: S(CCCN(C)C)c1c(NC(=O)/C=C/c2ccccc2)cccc1.

About UNSPSC 51292704

UNSPSC 51292704 Cinanserin, a Commodity code, does not align with the actual state and local procurement activity currently tagged under it. The three most recent opportunities posted under this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives for direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which involve cinanserin, an antidepressant pharmaceutical agent. The mismatch suggests a taxonomy classification error in the source systems rather than active procurement demand for cinanserin specifically at the state and local level.

The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple jurisdictions including Oregon). Recent opportunities show Seminole County seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually via IFB (response deadline July 26, 2023); Texas HHS issuing an RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026); and MMCAP issuing an RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. Activity appears concentrated in Florida and Texas with multistate cooperative purchasing involvement spanning the upper Midwest and Pacific Northwest. Given the code-to-solicitation mismatch, this Commodity code shows little relevant recent activity for the product it nominally describes.

Quick answers

What is UNSPSC 51292704?

UNSPSC 51292704 is Cinanserin, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51292704?

UNSPSC 51292704 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51292704

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code